Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine

被引:1
|
作者
Fu, Chuanxi [1 ]
Huang, Guihua [1 ]
Cui, Min [1 ]
Wang, Ming [1 ]
机构
[1] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
关键词
meningococcal meningitis; vaccine; safety; China; adverse reactions; DISEASE;
D O I
10.4161/hv.26347
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:138 / 139
页数:2
相关论文
共 50 条
  • [1] Post-licensure safety of the meningococcal group C conjugate vaccine
    Andrews, Nick
    Stowe, Julia
    Miller, Elizabeth
    Taylor, Brent
    [J]. HUMAN VACCINES, 2007, 3 (02): : 59 - 63
  • [2] BIVALENT SEROGROUP A/C MENINGOCOCCAL CONJUGATE VACCINE - SAFETY AND IMMUNOGENICITY IN TODDLERS
    LIEBERMAN, JM
    CHIU, SS
    WONG, VK
    PARTRIDGE, S
    CHANG, SJ
    CARLONE, GM
    WARD, JI
    [J]. PEDIATRIC RESEARCH, 1995, 37 (04) : A181 - A181
  • [3] A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study
    Velentgas, Priscilla
    Bohn, Rhonda L.
    Brown, Jeffrey S.
    Chan, K. Arnold
    Gladowski, Patricia
    Holick, Crystal N.
    Kramer, Judith M.
    Nakasato, Cynthia
    Spettell, Claire M.
    Walker, Alexander M.
    Zhang, Fang
    Platt, Richard
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (12) : 1226 - 1234
  • [4] SAFETY AND IMMUNOGENICITY OF MENINGOCOCCAL A-POLYSACCHARIDE AND C-POLYSACCHARIDE CONJUGATE VACCINE IN ADULTS
    ANDERSON, EL
    BOWERS, T
    MINK, CM
    KENNEDY, DJ
    BELSHE, RB
    HARAKEH, H
    PAIS, L
    HOLDER, P
    CARLONE, GM
    [J]. INFECTION AND IMMUNITY, 1994, 62 (08) : 3391 - 3395
  • [5] Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006
    McNicholas, Anne
    Galloway, Yvonne
    Stehr-Green, Paul
    Reid, Stewart
    Radke, Sarah
    Sexton, Kerry
    Kieft, Charlotte
    Macdonald, Claire
    Neutze, Jocelyn
    Drake, Ross
    Isaac, Dorothy
    O'Donnell, Mary
    Tatley, Michael
    Oster, Philipp
    O'Hallahan, Jane
    [J]. HUMAN VACCINES, 2007, 3 (05): : 196 - 204
  • [6] A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide-CRM197 with a meningococcal group C conjugate vaccine in healthy infants:: Challenge phase
    Riddell, Anna
    Buttery, Jim P.
    McVernon, Jodie
    Chantler, Tracey
    Lane, Laura
    Bowen-Morris, Jane
    Diggle, Linda
    Morris, Rhonwen
    Lockhart, Steven
    Pollard, Andrew J.
    Cartwright, Keith
    Moxon, E. Richard
    [J]. VACCINE, 2007, 25 (19) : 3906 - 3912
  • [7] Immunogenicity and safety of conjugate meningococcal group C vaccine in infants.
    Rennels, MB
    Edwards, KM
    Keyseding, HL
    Reisinger, KS
    Hogerman, DA
    Kimura, A
    Malinoski, FJ
    [J]. PEDIATRIC RESEARCH, 1996, 39 (04) : 1083 - 1083
  • [8] Molecular shape and immunogenicity of meningococcal polysaccharide group A conjugate vaccine
    Xu, Mengfang
    Xing, Xueqing
    Wu, Zhonghua
    Du, Yuguang
    Hu, Tao
    [J]. VACCINE, 2015, 33 (43) : 5815 - 5821
  • [9] VACCINE POTENTIAL OF MENINGOCOCCAL GROUP-C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
    BEUVERY, EC
    MIEDEMA, F
    VANDELFT, RW
    HAVERKAMP, J
    TIESJEMA, RH
    NAGEL, J
    [J]. JOURNAL OF INFECTION, 1983, 6 (03) : 247 - 255
  • [10] Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
    Richmond, P
    Kaczmarski, E
    Borrow, R
    Findlow, J
    Clark, S
    McCann, R
    Hill, J
    Barker, M
    Miller, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 761 - 764